Why This Anavex Life Sciences Analyst Is Lifting Their Price Target
A Cantor Fitzgerald analyst is incrementally bullish on shares of Anavex Life Sciences, Corp (NASDAQ: AVXL) after the release of Phase 2 data for the company's lead candidate.